Rare hereditary red blood cell enzymopathies associated with hemolytic anemia - pathophysiology, clinical aspects, and laboratory diagnosis

International Journal of Laboratory Hematology

Volumn 36, Issue 3, 2014, Pages 388-397

  Koralkova, P ^a   Van Solinge, W W ^b   Van Wijk, R ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anemia; Laboratory practice; RBC; RBC enzymes; RBC metabolism

Indexed keywords

BILIRUBIN; ERYTHROCYTE ENZYME; GLUTATHIONE REDUCTASE; GLYCOLYTIC ENZYME; HAPTOGLOBIN; LACTATE DEHYDROGENASE;

ANAEROBIC GLYCOLYSIS; BILIRUBIN BLOOD LEVEL; CELL FUNCTION; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EMBDEN MEYERHOF PATHWAY; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE METABOLISM; GENETIC DISORDER; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GLUTATHIONE METABOLISM; GLYCOLYSIS; HEMOLYTIC ANEMIA; HEREDITARY RED BLOOD CELL ENZYMOPATHY; HEXOSE MONOPHOSPHATE SHUNT; HIGH ENERGY PHOSPHATE; HUMAN; INBORN ERROR OF METABOLISM; INDEL MUTATION; LABORATORY DIAGNOSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; METABOLISM; NUCLEOTIDE METABOLISM; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PENTOSE PHOSPHATE CYCLE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PURINE METABOLISM; RARE DISEASE; REVIEW; SYSTEMATIC REVIEW; ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC; BLOOD EXAMINATION; ENZYMOLOGY; PATHOLOGY; PROCEDURES;

ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC; ERYTHROCYTES; GLYCOLYSIS; HEMATOLOGIC TESTS; HUMANS;

EID: 84898687040     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12223     Document Type: Review

References (51)

1. Arya R, Layton DM, Bellingham AJ. Hereditary red cell enzymopathies. Blood Rev 1995;9:165-75.
2. Jacobasch G, Rapoport SM. Hemolytic anemias due to erythrocyte enzyme deficiencies. Mol Aspects Med 1996;17:143-70.
3. van Wijk R, van Solinge WW. Disorders of red cells resulting from enzyme abnormalities. In: Williams Hematology. Kaushansky KJ, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal JT. (eds). New York: McGraw-Hill, 2010: 647-74.
4. Prchal JT, Gregg XT. Red cell enzymes. Hematology Am Soc Hematol Educ Program 2005;19-23. PMID:16304354.
5. Rapoport S, Luebering J. The formation of 2, 3-diphosphoglycerate in rabbit erythrocytes: the existence of a diphosphoglycerate mutase. J Biol Chem 1950;183:507-16.
6. van Zwieten R, Verhoeven AJ, Roos D. Inborn defects in the antioxidant systems of human red blood cells. Free Radic Biol Med 2014;67:377-86.
7. Dudzinska W, Hlynczak AJ, Skotnicka E, Suska M. The purine metabolism of human erythrocytes. Biochemistry (Mosc) 2006;71:467-75.
8. Valentine WN, Paglia DE. Erythrocyte disorders of purine and pyrimidine metabolism. Hemoglobin 1980;4:669-81.
9. Zanella A, Fermo E, Bianchi P, Valentini G. Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br J Haematol 2005;130:11-25.
10. van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood 2005;106:4034-42.
11. Beutler E, Gelbart T. Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population. Blood 2000;95:3585-8.
12. Kanno H, Fujii H, Miwa S. Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells. Biochem Biophys Res Commun 1992;188:516-23.
13. Valentine WN, Paglia DE. The primary cause of hemolysis in enzymopathies of anaerobic glycolysis: a viewpoint. Blood Cells 1980;6:819-29.
14. Oski FA, Marshall BE, Cohen PJ, Sugerman HJ, Miller LD. The role of the left-shifted or right-shifted oxygen-hemoglobin equilibrium curve. Ann Intern Med 1971;74:44-6.
15. Ferreira P, Morais L, Costa R, Resende C, Dias CP, Araújo F, Costa E, Barbot J, Vilarinho A. Hydrops fetalis associated with erythrocyte pyruvate kinase deficiency. Eur J Pediatr 2000;159:481-2.
16. Zanella A, Fermo E, Bianchi P, Chiarelli LR, Valentini G. Pyruvate kinase deficiency: the genotype-phenotype association. Blood Rev 2007;21:217-31.
17. Zanella A, Berzuini A, Colombo MB, Guffanti A, Lecchi L, Poli F, Cappellini MD, Barosi G. Iron status in red cell pyruvate kinase deficiency: study of Italian cases. Br J Haematol 1993;83:485-90.
18. Lin H-Y, Kao Y-H, Chen S-T, Meng M. Effects of inherited mutations on catalytic activity and structural stability of human glucose-6-phosphate isomerase expressed in Escherichia coli. Biochim Biophys Acta 2009;1794:315-23.
19. Matthay KK, Mentzer WC. Erythrocyte enzymopathies in the newborn. Clin Haematol 1981;10:31-55.
20. Schroter W, Eber SW, Bardosi A, Gahr M, Gabriel M, Sitzmann FC. Generalised glucosephosphate isomerase (GPI) deficiency causing haemolytic anaemia, neuromuscular symptoms and impairment of granulocytic function: a new syndrome due to a new stable GPI variant with diminished specific activity (GPI Homburg). Eur J Pediatr 1985;144:301-5.
21. Nakajima H, Raben N, Hamaguchi T, Yamasaki T. Phosphofructokinase deficiency; past, present and future. Curr Mol Med 2002;2:197-212.
22. Ahmed N, Battah S, Karachalias N, Babaei-Jadidi R, Horányi M, Baróti K, Hollan S, Thornalley PJ. Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency. Biochim Biophys Acta 2003;1639:121-32.
23. Orosz F, Oláh J, Ovádi J. Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim Biophys Acta 2009;1792:1168-74.
24. Beutler E, Scott S, Bishop A, Margolis N, Matsumoto F, Kuhl W. Red cell aldolase deficiency and hemolytic anemia: a new syndrome. Trans Assoc Am Physicians 1973;86:154-66.
25. Kreuder J, Borkhardt A, Repp R, Pekrun A, Göttsche B, Gottschalk U, Reichmann H, Schachenmayr W, Schlegel K, Lampert F. Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N Engl J Med 1996;334:1100-4.
26. (Arg303X/Cys338Tyr). Blood 2004;103:2401-3.
27. Esposito G, Vitagliano L, Costanzo P, Borrelli L, Barone R, Pavone L, Izzo P, Zagari A, Salvatore F. Human aldolase A natural mutants: relationship between flexibility of the C-terminal region and enzyme function. Biochem J 2004;380:51-6.
28. Kanno H. Hexokinase: gene structure and mutations. Baillieres Best Pract Res Clin Haematol 2000;13:83-8.
29. Kanno H, Murakami K, Hariyama Y, Ishikawa K, Miwa S, Fujii H. Homozygous intragenic deletion of type I hexokinase gene causes lethal hemolytic anemia of the affected fetus. Blood 2002;100:1930.
30. Fermo E, Bianchi P, Chiarelli LR, Maggi M, Mandarà GM, Vercellati C, Marcello AP, Barcellini W, Cortelezzi A, Valentini G, Zanella A. A new variant of phosphoglycerate kinase deficiency (p. I371K) with multiple tissue involvement: molecular and functional characterization. Mol Genet Metab 2012;106:455-61.
31. Cohen-Solal M, Valentin C, Plassa F, Guillemin G, Danze F, Jaisson F, Rosa R. Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Creteil and PGK Amiens. Blood 1994;84:898-903.
32. Spiegel R, Gomez EA, Akman HO, Krishna S, Horovitz Y, DiMauro S. Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations. Neuromuscul Disord 2009;19:207-11.
33. Sotiriou E, Greene P, Krishna S, Hirano M, DiMauro S. Myopathy and parkinsonism in phosphoglycerate kinase deficiency. Muscle Nerve 2010;41:707-10.
34. Beutler E. PGK deficiency. Br J Haematol 2007;136:3-11.
35. Beutler E. Red cell enzyme defects as nondiseases and as diseases. Blood 1979;54:1-7.
36. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009;42:267-78.
37. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371:64-74.
38. Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol 2014;164:469-80.
39. Kamerbeek NM, van Zwieten R, de Boer M, Morren G, Vuil H, Bannink N, Lincke C, Dolman KM, Becker K, Schirmer RH, Gromer S, Roos D. Molecular basis of glutathione reductase deficiency in human blood cells. Blood 2007;109:3560-6.
40. Ristoff E, Larsson A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2007;2:16.
41. Valentine WN, Fink K, Paglia DE, Harris SR, Adams WS. Hereditary hemolytic anemia with human erythrocyte pyrimidine 5′-nucleotidase deficiency. J Clin Invest 1974;54:866-79.
42. Zanella A, Bianchi P, Fermo E, Valentini G. Hereditary pyrimidine 5′-nucleotidase deficiency: from genetics to clinical manifestations. Br J Haematol 2006;133:113-23.
43. Rees DC, Duley JA, Marinaki AM. Pyrimidine 5′ nucleotidase deficiency. Br J Haematol 2003;120:375-83.
44. Abrusci P, Chiarelli LR, Galizzi A, Fermo E, Bianchi P, Zanella A, Valentini G. Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia. Exp Hematol 2007;35:1182-9.
45. Chen EH, Mitchell BS. Hereditary overexpression of adenosine deaminase in erythrocytes: studies in erythroid cell lines and transgenic mice. Blood 1994;84:2346-53.
46. Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc 2003;78:1274-80.
47. Shah SS, Diakite SA, Traore K, Diakite M, Kwiatkowski DP, Rockett KA, Wellems TE, Fairhurst RM. A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency. Sci Rep 2012;2:299.
48. Beutler E. Red Cell Metabolism. A Manual of Biochemical Methods. Orlando: Grune & Stratton; 1984: 188.
49. Bain BJ. Diagnosis from the blood smear. N Engl J Med 2005;353:498-507.
50. van Wijk R, van Solinge WW, Nerlov C, Beutler E, Gelbart T, Rijksen G, Nielsen FC. Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. Blood 2003;101:1596-602.
51. de Vooght KMK, van Solinge WW, van Wesel AC, Kersting S, van Wijk R. First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysis. Haematologica 2009;94:1203-10.